EcoDrugPlus

Prostaglandin E Receptor 4

Ensembl ID : ENSPEMG00000028671
Gene Symbol: PTGER4
3 Cross references
274 Possible Orthologues:

Prostaglandin F Receptor

Ensembl ID : ENSPEMG00000029819
Gene Symbol: PTGFR
3 Cross references
195 Possible Orthologues:

Prostaglandin I Receptor (Ip)

Ensembl ID : ENSPEMG00000016407
Gene Symbol: PTGIR
1 Cross references
187 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSPEMG00000017869
Gene Symbol: PTGS1
3 Cross references
256 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 2

Ensembl ID : ENSPEMG00000010420
Gene Symbol: PTGS2
3 Cross references
237 Possible Orthologues:

Proteasome (Prosome, Macropain) 26s Subunit, Atpase, 4

Ensembl ID : ENSPEMG00000000634
Gene Symbol: PSMC4
1 Cross references
197 Possible Orthologues:

Proteasome (Prosome, Macropain) 26s Subunit, Atpase, 6

Ensembl ID : ENSPEMG00000023390
Gene Symbol: PSMC6
1 Cross references
154 Possible Orthologues:

Proteasome (Prosome, Macropain) Subunit, Beta Type, 11

Ensembl ID : ENSPEMG00000026627
Gene Symbol: PSMB11
1 Cross references
227 Possible Orthologues:

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSPEMG00000011421
Gene Symbol: PSMA1
3 Cross references
254 Possible Orthologues:

Proteasome 20s Subunit Alpha 2

Ensembl ID : ENSPEMG00000000680
Gene Symbol: PSMA2
3 Cross references
235 Possible Orthologues:

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSPEMG00000015781
Gene Symbol: PSMA3
3 Cross references
229 Possible Orthologues:

Proteasome 20s Subunit Alpha 4

Ensembl ID : ENSPEMG00000020094
Gene Symbol: PSMA4
3 Cross references
241 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).